Ansell Limited (ASX:ANN)
Australia · Delayed Price · Currency is AUD 31.84
+0.16 (0.51%)
Jul 21, 2026, 4:10 PM AEST
Ansell Market Cap
Ansell has a market cap or net worth of 4.42 billion as of July 21, 2026. Its market cap has decreased by -1.54% in one year.
Market Cap
4.42B
Enterprise Value
5.34B
Revenue
3.01B
Ranking
n/a
PE Ratio
22.86
Stock Price
31.84
ChartMarket Cap Chart
Since January 16, 1992, Ansell's market cap has decreased from 5.00B to 4.42B, a decrease of -11.49%. That is a compound annual growth rate of -0.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 4.42B | -11.37% |
| Dec 31, 2025 | 4.99B | 1.96% |
| Dec 31, 2024 | 4.89B | 56.70% |
| Dec 29, 2023 | 3.12B | -12.08% |
| Dec 30, 2022 | 3.55B | -11.25% |
| Dec 31, 2021 | 4.00B | -10.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 58.72B |
| Sigma Healthcare | 33.70B |
| Pro Medicus | 19.55B |
| Sonic Healthcare | 10.71B |
| Ramsay Health Care | 9.91B |
| Cochlear | 7.81B |
| Telix Pharmaceuticals | 5.13B |
| Mesoblast | 3.15B |